In the early days of the coronavirus outbreak, New York’s death toll appears to be rising at a faster rate than any other state and most other countries.

Governor Cuomo reported that 210 New Yorkers had died from the disease as of Tuesday – a higher number than all but eight countries in the world.


This is an installment in a special series of #NYCoronaVirus Chronicles by Empire Center analysts, focused on New York’s state and local policy response to the Coronavirus pandemic.


It crossed the 200 mark just 11 days after recording its first death on March 13. The comparable time for Italy, the world’s hardest-hit nation, was 15 days.

As shown in the first chart below – modeled on graphics produced by The New York Times – New York’s toll is roughly doubling every two days, putting it on a relatively steep track compared to the rest of the world. 

The second chart shows the same trends on a linear as opposed to logarithmic scale.

Sources: Worldometer, NYS governor’s office, Empire Center calculations (Click to enlarge)

New York has also recorded the largest number of diagnosed cases in the U.S., and among the largest in the world. That metric is likely distorted by the state’s higher rate of testing – which has the potential to catch mild cases that otherwise would have gone unnoticed. For that reason, the death count may give a clearer picture of the outbreak’s scale.

It’s also a lagging indicator: Estimates of the incubation period for the virus range from two to 14 days, meaning the New Yorkers dying now may have first been exposed weeks ago. It also means that it could be early to mid-April before the state’s and the nation’s dramatic efforts to slow the spread – through “social distancing” and the governor’s tight restrictions on public gatherings, businesses and other activities – and other efforts to contain the spread begin to slow the rising death toll.

In short, New Yorkers should brace themselves for worse to come.

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More